logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 4
  • 1
    Waterhouse, Janette, Dr
    Chemist born in March 1952
    Individual (2 offsprings)
    Officer
    2012-11-27 ~ now
    OF - Director → CIF 0
    Dr Janette Waterhouse
    Born in March 1952
    Individual (2 offsprings)
    Person with significant control
    2016-04-07 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
  • 2
    Leaf, Gail
    Individual (1 offspring)
    Officer
    2012-11-27 ~ now
    OF - Secretary → CIF 0
  • 3
    Paul Stanley
    Individual (209 offsprings)
    Insolvency
    2017-10-24 ~ now
    IP - (Case 1) practitioner → CIF 0
  • 4
    Jason Dean Greenhalgh
    Individual (501 offsprings)
    Insolvency
    2017-10-24 ~ now
    IP - (Case 1) practitioner → CIF 0
parent relation
Company in focus

HIGHFIELD PHARMACEUTICAL CONSULTING LIMITED

Period: 2012-11-27 ~ 2018-11-09
Company number: 08309624
Registered name
HIGHFIELD PHARMACEUTICAL CONSULTING LIMITED - Dissolved
Insolvency (Case 1) Members voluntary liquidation
Commencement of winding up on 2017-10-24
Dissolved on 2018-11-09
Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Par Value of Share
Class 1 ordinary share
1 GBP2015-12-01 ~ 2017-03-31
Debtors
23,089 GBP2017-03-31
282 GBP2015-11-30
Cash at bank and in hand
128,167 GBP2017-03-31
146,861 GBP2015-11-30
Current Assets
151,256 GBP2017-03-31
147,143 GBP2015-11-30
Current liabilities
83,006 GBP2017-03-31
69,050 GBP2015-11-30
Net Current Assets/Liabilities
68,250 GBP2017-03-31
78,093 GBP2015-11-30
Total Assets Less Current Liabilities
68,250 GBP2017-03-31
78,093 GBP2015-11-30
Called-up share capital
1 GBP2017-03-31
1 GBP2015-11-30
Retained earnings
68,249 GBP2017-03-31
78,092 GBP2015-11-30
Shareholder's fund
68,250 GBP2017-03-31
78,093 GBP2015-11-30
Number of shares allotted
Class 1 ordinary share
1 shares2017-03-31
Paid-up share capital
Class 1 ordinary share
1 GBP2017-03-31
1 GBP2015-11-30

  • HIGHFIELD PHARMACEUTICAL CONSULTING LIMITED
    Info
    Registered number 08309624
    1 Old Hall Street, Liverpool L3 9HF
    PRIVATE LIMITED COMPANY incorporated on 2012-11-27 and dissolved on 2018-11-09 (5 years 11 months). The status of the company number is Dissolved.
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.